SULLIVANS PHARMACY has sponsored the creation of one or more 401k plans.
Submission information for form 5500 for 401k plan SULLIVAN'S PHARMACY 401(K) PLAN
Measure | Date | Value |
---|
2022 : SULLIVAN'S PHARMACY 401(K) PLAN 2022 401k financial data |
---|
Total unrealized appreciation/depreciation of assets | 2022-12-31 | $0 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2022-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2022-12-31 | $0 |
Total income from all sources (including contributions) | 2022-12-31 | $-1,671,931 |
Total loss/gain on sale of assets | 2022-12-31 | $0 |
Total of all expenses incurred | 2022-12-31 | $2,042,193 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2022-12-31 | $2,005,058 |
Expenses. Certain deemed distributions of participant loans | 2022-12-31 | $7,341 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2022-12-31 | $523,999 |
Value of total assets at end of year | 2022-12-31 | $10,339,617 |
Value of total assets at beginning of year | 2022-12-31 | $14,053,741 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2022-12-31 | $29,794 |
Total interest from all sources | 2022-12-31 | $16,767 |
Total dividends received (eg from common stock, registered investment company shares) | 2022-12-31 | $567,100 |
Total dividends received from registered investment company shares (eg mutual funds) | 2022-12-31 | $567,100 |
Was this plan covered by a fidelity bond | 2022-12-31 | Yes |
Value of fidelity bond cover | 2022-12-31 | $500,000 |
If this is an individual account plan, was there a blackout period | 2022-12-31 | No |
Were there any nonexempt tranactions with any party-in-interest | 2022-12-31 | No |
Contributions received from participants | 2022-12-31 | $351,155 |
Participant contributions at end of year | 2022-12-31 | $172,766 |
Participant contributions at beginning of year | 2022-12-31 | $209,512 |
Administrative expenses (other) incurred | 2022-12-31 | $29,794 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2022-12-31 | No |
Value of net income/loss | 2022-12-31 | $-3,714,124 |
Value of net assets at end of year (total assets less liabilities) | 2022-12-31 | $10,339,617 |
Value of net assets at beginning of year (total assets less liabilities) | 2022-12-31 | $14,053,741 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2022-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2022-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2022-12-31 | No |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2022-12-31 | $9,718,960 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2022-12-31 | $13,465,081 |
Interest on participant loans | 2022-12-31 | $11,153 |
Interest earned on other investments | 2022-12-31 | $5,614 |
Value of funds held in insurance company general accounts (unallocated contracts) at end of year | 2022-12-31 | $447,891 |
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year | 2022-12-31 | $379,148 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2022-12-31 | $-2,779,797 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2022-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2022-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2022-12-31 | No |
Contributions received in cash from employer | 2022-12-31 | $172,844 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2022-12-31 | $2,005,058 |
Did the plan have assets held for investment | 2022-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2022-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2022-12-31 | No |
Opinion of an independent qualified public accountant for this plan | 2022-12-31 | Disclaimer |
Accountancy firm name | 2022-12-31 | G.T. REILLY & COMPANY |
Accountancy firm EIN | 2022-12-31 | 042513210 |
2021 : SULLIVAN'S PHARMACY 401(K) PLAN 2021 401k financial data |
---|
Unrealized appreciation/depreciation of other (non real estate) assets | 2021-12-31 | $3,701 |
Total unrealized appreciation/depreciation of assets | 2021-12-31 | $3,701 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2021-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2021-12-31 | $0 |
Total income from all sources (including contributions) | 2021-12-31 | $2,870,884 |
Total loss/gain on sale of assets | 2021-12-31 | $0 |
Total of all expenses incurred | 2021-12-31 | $3,050,547 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2021-12-31 | $3,005,383 |
Expenses. Certain deemed distributions of participant loans | 2021-12-31 | $8,966 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2021-12-31 | $564,711 |
Value of total assets at end of year | 2021-12-31 | $14,053,741 |
Value of total assets at beginning of year | 2021-12-31 | $14,233,404 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2021-12-31 | $36,198 |
Total interest from all sources | 2021-12-31 | $14,394 |
Total dividends received (eg from common stock, registered investment company shares) | 2021-12-31 | $760,804 |
Total dividends received from registered investment company shares (eg mutual funds) | 2021-12-31 | $760,804 |
Was this plan covered by a fidelity bond | 2021-12-31 | Yes |
Value of fidelity bond cover | 2021-12-31 | $500,000 |
If this is an individual account plan, was there a blackout period | 2021-12-31 | No |
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2021-12-31 | $0 |
Were there any nonexempt tranactions with any party-in-interest | 2021-12-31 | No |
Contributions received from participants | 2021-12-31 | $378,882 |
Participant contributions at end of year | 2021-12-31 | $209,512 |
Participant contributions at beginning of year | 2021-12-31 | $303,760 |
Administrative expenses (other) incurred | 2021-12-31 | $36,198 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2021-12-31 | No |
Value of net income/loss | 2021-12-31 | $-179,663 |
Value of net assets at end of year (total assets less liabilities) | 2021-12-31 | $14,053,741 |
Value of net assets at beginning of year (total assets less liabilities) | 2021-12-31 | $14,233,404 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2021-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2021-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2021-12-31 | No |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2021-12-31 | $13,465,081 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2021-12-31 | $13,571,126 |
Interest on participant loans | 2021-12-31 | $14,394 |
Value of funds held in insurance company general accounts (unallocated contracts) at end of year | 2021-12-31 | $379,148 |
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year | 2021-12-31 | $358,518 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2021-12-31 | $1,527,274 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2021-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2021-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2021-12-31 | No |
Contributions received in cash from employer | 2021-12-31 | $185,829 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2021-12-31 | $3,005,383 |
Did the plan have assets held for investment | 2021-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2021-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2021-12-31 | No |
Opinion of an independent qualified public accountant for this plan | 2021-12-31 | Disclaimer |
Accountancy firm name | 2021-12-31 | G.T. REILLY & COMPANY |
Accountancy firm EIN | 2021-12-31 | 042513210 |
2020 : SULLIVAN'S PHARMACY 401(K) PLAN 2020 401k financial data |
---|
Unrealized appreciation/depreciation of other (non real estate) assets | 2020-12-31 | $2,645 |
Total unrealized appreciation/depreciation of assets | 2020-12-31 | $0 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2020-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2020-12-31 | $0 |
Total income from all sources (including contributions) | 2020-12-31 | $2,755,374 |
Total loss/gain on sale of assets | 2020-12-31 | $0 |
Total of all expenses incurred | 2020-12-31 | $814,035 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2020-12-31 | $780,304 |
Expenses. Certain deemed distributions of participant loans | 2020-12-31 | $5,173 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2020-12-31 | $600,136 |
Value of total assets at end of year | 2020-12-31 | $14,109,505 |
Value of total assets at beginning of year | 2020-12-31 | $12,168,166 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2020-12-31 | $28,558 |
Total interest from all sources | 2020-12-31 | $22,486 |
Total dividends received (eg from common stock, registered investment company shares) | 2020-12-31 | $430,626 |
Total dividends received from registered investment company shares (eg mutual funds) | 2020-12-31 | $430,626 |
Was this plan covered by a fidelity bond | 2020-12-31 | Yes |
Value of fidelity bond cover | 2020-12-31 | $500,000 |
If this is an individual account plan, was there a blackout period | 2020-12-31 | No |
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2020-12-31 | $0 |
Were there any nonexempt tranactions with any party-in-interest | 2020-12-31 | No |
Contributions received from participants | 2020-12-31 | $402,101 |
Participant contributions at end of year | 2020-12-31 | $303,760 |
Participant contributions at beginning of year | 2020-12-31 | $293,961 |
Administrative expenses (other) incurred | 2020-12-31 | $28,558 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2020-12-31 | No |
Value of net income/loss | 2020-12-31 | $1,941,339 |
Value of net assets at end of year (total assets less liabilities) | 2020-12-31 | $14,109,505 |
Value of net assets at beginning of year (total assets less liabilities) | 2020-12-31 | $12,168,166 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2020-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2020-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2020-12-31 | No |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2020-12-31 | $13,571,126 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2020-12-31 | $11,737,681 |
Interest on participant loans | 2020-12-31 | $20,602 |
Interest earned on other investments | 2020-12-31 | $1,884 |
Value of funds held in insurance company general accounts (unallocated contracts) at end of year | 2020-12-31 | $234,619 |
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year | 2020-12-31 | $136,524 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2020-12-31 | $1,702,126 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2020-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2020-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2020-12-31 | No |
Contributions received in cash from employer | 2020-12-31 | $198,035 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2020-12-31 | $780,304 |
Did the plan have assets held for investment | 2020-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2020-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2020-12-31 | No |
Opinion of an independent qualified public accountant for this plan | 2020-12-31 | Disclaimer |
Accountancy firm name | 2020-12-31 | G.T. REILLY & COMPANY |
Accountancy firm EIN | 2020-12-31 | 042513210 |